重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

产品说明书

FAQ

COA

已发表文献

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy.  

 

产品性质

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike RBD (N501Y,K417N,E484K) Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Arg319  Phe541 ( N501Y, K417N, E484K).

分子量

Approximately 26.2 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-COV-2 Spike RBD (N501Y, K417N, E484K) , His Tag at 0.5μg/ml (100ul/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 23.3ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)
重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

HB220811

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

暂无内容

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

暂无内容

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy.  

 

产品性质

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike RBD (N501Y,K417N,E484K) Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Arg319  Phe541 ( N501Y, K417N, E484K).

分子量

Approximately 26.2 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-COV-2 Spike RBD (N501Y, K417N, E484K) , His Tag at 0.5μg/ml (100ul/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 23.3ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)
重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

HB220811

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

暂无内容

重组SARS-COV-2刺突RBD(N501Y/K417N/E484K)(His标签)

暂无内容

TwistBioscience SARS-CoV-2 RNA产品

 Twist Bioscience,我们为正在改变世界的客户服务。在医药,农业,工业化学品和数据存储等领域,通过使用我们的合成DNA工具,我们的客户正在开发改善人们生活和改善地球可持续性的方法

 

Twist*的基于硅的DNA书写平台可快速开发用于病毒检测和表征样品的NGS面板,而我们的克隆基因基因片段可从一种或多种抗原呈递病毒基因或肽序列快速开发亚单位疫苗,从而无需科学家处理活的和潜在危险的病原体,并大限度地减少了克隆DNA的片段所需的时间。

呼吸道病毒研究小组

Twist呼吸道病毒研究小组可从单个样品中检测多种病毒病原体,每个病毒可检测到多达100份病毒材料。结合One Codex的分析,研究人员可以生成带有病毒物种鉴定的报告,并创建可用于出版物的可视化。

 

TwistBioscience SARS-CoV-2 RNA产品

  • 带有一种Codex软件的Twist呼吸道病毒研究小组,2种反应,试剂盒-SKU:103066
  • 带有一种Codex软件的Twist呼吸道病毒研究小组,12种反应,试剂盒-SKU:103067
  • 带有一种Codex软件的Twist呼吸道病毒研究小组,96次反应,试剂盒-SKU:103068

相关资源:

  • [产品表] Twist呼吸道病毒研究小组

合成SARS-CoV-2 RNA对照

阳性对照可提供质量控制措施,以验证和验证即时诊断项目,包括下一代测序(NGS)和逆转录酶-聚合酶链反应(RT-PCR)分析。 

Twist提供了*合成的SARS-CoV-2 RNA对照,可用于6个不同的参考序列:

  • Twist合成SARS-CoV-2 RNA对照1(MT007544.1)-SKU:102019
  • Twist合成SARS-CoV-2 RNA对照2(MN908947.3)-SKU:102024
  • Twist综合SARS-CoV-2 RNA对照3(LC528232.1)– SKU:102860
  • Twist合成SARS-CoV-2 RNA对照4(MT106054.1)– SKU:102862
  • Twist Synthetic SARS-CoV-2 RNA Control 5(MT192765)– SKU:102917
  • Twist合成SARS-CoV-2 RNA对照6(MT118835)– SKU:102918
  • 102916:控件(1-6)

相关资源:

  • [产品说明书]合成SARS-CoV-2 RNA对照

SARS-CoV-2研究小组

除了强大的RNA标准外,Twist还提供仅研究用(RUO)靶标富集NGS面板,用于病毒检测和样品表征。这些面板可用于环境监测和监视测试,同时还提供对用于监测病毒进化和菌株起源的全序列信息的洞察力。

  • Twist SARS-CoV-2研究小组,2个反应,试剂盒-SKU:102016
  • Twist SARS-CoV-2研究小组,12个反应,试剂盒-SKU:102017
  • Twist SARS-CoV-2研究小组,96次反应,试剂盒-SKU:102018

 

 

IPA确认发现了针对SARS-CoV-2的完*有效的中和抗体

 

IPA确认发现了针对SARS-CoV-2的完*有效的中和抗体

IPA宣布发现来自人类和骆驼(VHH)的功能抗体,这些抗体已使用IPA噬菌体展示技术鉴定。

维多利亚,2020年6月29 日 –IMMUNOPRECISE ANTIBODIES LTD。(“公司”或“ IPA”)(TSX VENTURE:IPA)(OTCQB:IPATF)(FSE:TQB2),是提供方位服务的治疗性抗体发现和开发的经验丰富的,今天宣布了对众多潜在候选抗体的鉴定具有强效的体外中和活性,可用于进一步测试,并可能包含在公司的PolyTopeTM mAb疗法中,以对抗COVID19大流行。

2020 年3月12 日,ImmunoPrecise宣布了目前正在开展的一些临床前计划,以协助抗击SARS-CoV-2。今天的公告更新了该公司在开发PolyTope™mAb疗法方面的进展,该疗法旨在治疗重症患者,并保护高危人群,例如暴露于病毒,一线工人,老年人和免疫功能低下的人群。

ImmunoPrecise部署了几个专有的发现平台,这些平台利用了人类,美洲驼,兔和Ligand Pharmaceutical(NASDAQ:LGND)的OmniAb®基因工程大鼠产生人类抗体的免疫系统。今天宣布的中和抗体是从人类和美洲驼战役中分析的前300种抗体进行功能筛选的结果。该公司表示,对兔子和OmniAb大鼠运动中剩余的1300种先导抗体的功能分析是独立进行的,他们预计不久的将来会从这些其他程序中发布初步的功能数据筛选。

IPA执行官兼总裁Jennifer Bath博士说:“在我们的初步研究中,这个关键时刻到达了许多*的功能性治疗候选药物,这表明IPA的抗COVID19计划具有广泛的科学范围。” “针对COVID19的有效鸡尾酒疗法,针对该病毒的多个表位,可以证明以有效和持久的方式对抗这种流行病至关重要。”

该公司的科学方法已导致了多种候选先导抗体,并且迄今为止,已经产生了针对多种表位的许多强力中和抗体,支持了该公司的目标,即使在SARS-CoV-2继续发展的情况下,也能保持疗效。 。为了进一步支持公司强大的科学方法,IPA正在准备测试这些先导抗体是否针对其他有文件证明的病毒突变株。

公司预计临床前研究将于2020年夏季开始。

ImmunoPrecise执行官Jennifer Bath博士已审查并批准了此新闻稿的科学披露。

在临床试验中对人类使用治疗药物需要获得政府监管机构的批准,例如,公司未明示或暗示声称其产品具有消除,治愈或含有COVID19(或SARS-CoV)的能力-2)。

关于ImmunoPrecise抗体有限公司

ImmunoPrecise是一家提供方位服务的治疗性抗体发现合同研究组织,为制药客户在较短的时间内为其提供与物种无关的,多格式,特征化和工程化的人类单克隆抗体

 

 

前瞻性信息

本新闻稿包含的声明在一定程度上不是对历史事实的叙述,可能构成适用的加拿大证券法所定义的“前瞻性声明”。公司使用诸如“可能”,“将要”,“可能”,“将要”,“可能”,“期望”,“相信”,“打算”等词语来表述前瞻性陈述。任何此类前瞻性陈述均基于ImmunoPrecise的经验和对历史趋势,当前状况和预期未来发展的理解,并基于这些假设和分析。但是,实际结果和发展是否符合ImmunoPrecise的期望和预测会受到许多风险,假设和不确定性的影响。许多因素可能导致ImmunoPrecise的实际结果与本新闻稿中包含的前瞻性陈述所表达或暗示的结果有实质性差异。这些因素包括,除其他因素外,ImmunoPrecise可能无法成功开发用于预防,治疗或诊断SARS-CoV-2的任何疫苗,疗法或诊断试剂盒,IPA的实际收入和收益低于因COVID19大流行而产生的预期潜在负面影响,例如监管审查延迟,制造和临床试验,供应链中断和经济中断,以及ImmunoPrecise年度管理讨论和分析中描述的那些风险和不确定性。截至2020年1月31日的上一季度,此处包含的“前瞻性陈述”仅是截至本新闻发布之日为止,除非适用法律要求,否则ImmunoPrecise不承担由于新信息,未来事件或其他原因而公开更新或修改此类信息的义务。除此以外。

 

源自u-proteinexpress

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

产品说明书

FAQ

COA

已发表文献

 

Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N) . The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 . The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). First detected in India in December 2020, the B.1.617.2, or Delta variant, is considered a Variant of Concern (VOC) .

 

产品信息

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Delta B.1.617.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19R, G142D, E156G, HR157-158 del, L452R, T478K, D614G, P681R).

分子量

Approximately 75.92 kDa. Due to glycosylation, the protein migrates to 90-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by Tris-Bis PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Delta B.1.617.2) , His Tag at 0.5μg/ml (100 μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 21.8ng/ml determined by ELISA.

内毒素

< 1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

储存条件

The product should be stored at -25~-15℃ for 1 year.

1 month, 2 ~8 °C under sterile conditions after reconstitution.

3 months, -25~-15℃ °C under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

注意事项

1.Please operate with lab coats and disposable glovesfor your safety

2.This product is for research use only.

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

暂无内容

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

暂无内容

 

Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N) . The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 . The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). First detected in India in December 2020, the B.1.617.2, or Delta variant, is considered a Variant of Concern (VOC) .

 

产品信息

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Delta B.1.617.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19R, G142D, E156G, HR157-158 del, L452R, T478K, D614G, P681R).

分子量

Approximately 75.92 kDa. Due to glycosylation, the protein migrates to 90-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by Tris-Bis PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Delta B.1.617.2) , His Tag at 0.5μg/ml (100 μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 21.8ng/ml determined by ELISA.

内毒素

< 1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

储存条件

The product should be stored at -25~-15℃ for 1 year.

1 month, 2 ~8 °C under sterile conditions after reconstitution.

3 months, -25~-15℃ °C under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

注意事项

1.Please operate with lab coats and disposable glovesfor your safety

2.This product is for research use only.

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

暂无内容

Recombinant SARS-COV-2 Spike S1(Delta B.1.617.2) Protein His标签重组SARS-COV-2刺突S1(Delta B.1.617.2)蛋白

暂无内容

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

产品说明书

FAQ

COA

已发表文献

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2. In SARS-CoV-2, as with most coronaviruses, proteolytic cleavage of the S protein into S1 and S2 subunits is required for activation. The S1 subunit is focused on attachment of the protein to the host receptor, while the S2 subunit is involved with cell fusion. The S1 subunit can be further divided into an N-terminal domain (NTD) and a receptor binding domain (RBD). The SARS-CoV-2 NTD shares 50% and 20% amino acid (aa) sequence identity with the NTD of SARS-CoV-1 and MERS-CoV, respectively. The NTD is reported to bind L-SIGN and DC-SIGN in cells that don't express the ACE-2 receptor. Despite being heavily glycosylated, the NTD is capable of eliciting an immune response to produce potent neutralization antibodies, although at a reduced level than the ones targeting the RBD. Three immunogenic regions have been identified in the NTD: aa 14-20, aa 140-158, and aa 245-264. Antibody cocktails targeting both NTD and RBD could provide better protection against SARS-CoV-2 infection.

 

产品性质

别名

S1 protein NTD,Spike glycoprotein Subunit1 NTD,S glycoprotein Subunit1 NTD,Spike protein S1 NTD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike S1 NTD Protein is expressed from HEK293 Cells with His tag and Flag tag at the C-terminal. It contains Val16-Ser305.

分子量

Approximately 35 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

 

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突S1-NTD(His-Flag标签)
 

HB220811

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

暂无内容

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

暂无内容

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2. In SARS-CoV-2, as with most coronaviruses, proteolytic cleavage of the S protein into S1 and S2 subunits is required for activation. The S1 subunit is focused on attachment of the protein to the host receptor, while the S2 subunit is involved with cell fusion. The S1 subunit can be further divided into an N-terminal domain (NTD) and a receptor binding domain (RBD). The SARS-CoV-2 NTD shares 50% and 20% amino acid (aa) sequence identity with the NTD of SARS-CoV-1 and MERS-CoV, respectively. The NTD is reported to bind L-SIGN and DC-SIGN in cells that don't express the ACE-2 receptor. Despite being heavily glycosylated, the NTD is capable of eliciting an immune response to produce potent neutralization antibodies, although at a reduced level than the ones targeting the RBD. Three immunogenic regions have been identified in the NTD: aa 14-20, aa 140-158, and aa 245-264. Antibody cocktails targeting both NTD and RBD could provide better protection against SARS-CoV-2 infection.

 

产品性质

别名

S1 protein NTD,Spike glycoprotein Subunit1 NTD,S glycoprotein Subunit1 NTD,Spike protein S1 NTD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike S1 NTD Protein is expressed from HEK293 Cells with His tag and Flag tag at the C-terminal. It contains Val16-Ser305.

分子量

Approximately 35 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

 

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突S1-NTD(His-Flag标签)
 

HB220811

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

暂无内容

重组SARS-COV-2刺突S1-NTD(His-Flag标签)

暂无内容

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

产品说明书

FAQ

COA

已发表文献

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHO60594.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike S1 (Omicron B.1.1.529) Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Gln14-Arg683(A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H).

分子量

Approximately 76.38 kDa. Due to glycosylation, the protein migrates to 130-145 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized Human ACE2, hFc Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for SARS-COV-2 Spike S1 (Omicron B.1.1.529) , His Tag with the EC50 of 0.8μg/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

 

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突S1(奥密克戎)(His标签)
重组SARS-COV-2刺突S1(奥密克戎)(His标签)

 

HB220811

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

暂无内容

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

暂无内容

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHO60594.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike S1 (Omicron B.1.1.529) Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Gln14-Arg683(A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H).

分子量

Approximately 76.38 kDa. Due to glycosylation, the protein migrates to 130-145 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized Human ACE2, hFc Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for SARS-COV-2 Spike S1 (Omicron B.1.1.529) , His Tag with the EC50 of 0.8μg/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

 

冰袋运输-20-80存,一年有效期

复溶后,20 -80°C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

1. 避免反复冻融。

2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

3. 本产品仅作科研用途!

 

产品数据

重组SARS-COV-2刺突S1(奥密克戎)(His标签)
重组SARS-COV-2刺突S1(奥密克戎)(His标签)

 

HB220811

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

暂无内容

重组SARS-COV-2刺突S1(奥密克戎)(His标签)

暂无内容

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

产品说明书

FAQ

COA

已发表文献

 

Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N) . The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 . The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2).

 

产品信息

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike RBD (Omicron XBB) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Arg319-Phe541(G339H, R346T, L368I, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486S, F490S, Q498R, N501Y, Y505H).

分子量

Approximately 26.21 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike RBD (Omicron XBB) at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 27.0ng/ml determined by ELISA.

内毒素

< 1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

储存条件

The product should be stored at -25~-15℃.

1 month, 2 ~8 °C under sterile conditions after reconstitution.

3 months, -25~-15℃ °C under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

注意事项

1.Please operate with lab coats and disposable glovesfor your safety

2.This product is for research use only.

 

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

暂无内容

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

暂无内容

 

Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N) . The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 . The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2).

 

产品信息

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike RBD (Omicron XBB) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Arg319-Phe541(G339H, R346T, L368I, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486S, F490S, Q498R, N501Y, Y505H).

分子量

Approximately 26.21 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike RBD (Omicron XBB) at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 27.0ng/ml determined by ELISA.

内毒素

< 1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

储存条件

The product should be stored at -25~-15℃.

1 month, 2 ~8 °C under sterile conditions after reconstitution.

3 months, -25~-15℃ °C under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

注意事项

1.Please operate with lab coats and disposable glovesfor your safety

2.This product is for research use only.

 

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

暂无内容

重组SARS-COV-2刺突RBD蛋白(Omicron XBB) His标签

暂无内容

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

产品说明书

FAQ

COA

已发表文献

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.    

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19I, L24S, PPA25-27del, HV69-70del, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H).

分子量

Approximately 75.76 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) , His Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 85.6ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输。-20 ℃保存,一年有效期。

复溶后,-20 °C,在未开封状态下保存 3-6 个月。复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装冻存,避免反复冻融。

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!

HB221222

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.    

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19I, L24S, PPA25-27del, HV69-70del, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H).

分子量

Approximately 75.76 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) , His Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 85.6ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输。-20 ℃保存,一年有效期。

复溶后,-20 °C,在未开封状态下保存 3-6 个月。复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装冻存,避免反复冻融。

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!

HB221222

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

nanohelix SARS-CoV-2 多重检测简介

 

nanohelix SARS-CoV-2 多重检测简介
[仅供研究使用]

  • SARS-CoV-2 的直接、快速、可靠和多基因检测

  • 直接:适用于纯化的 RNA 和未纯化的样本

  • 快速: 50 分钟 [样品制备 5 分钟 + qRT-PCR 45 分钟/40 个循环]

  • 可靠:针对 SARS-CoV-2(S、ORF8、N)和人类(RNase P)的 4 种目标检测

  • UDG 系统:防止残留污染

产品

货号 产品 尺寸
DFSCV100 DirectFast™ SARS-CoV-2 多重检测 [仅供研究使用] 100 次

描述:


SARS-CoV-2 多重检测

[仅供研究使用]

  • SARS-CoV-2 的直接、快速、可靠和多基因检测

  • 直接:适用于纯化的 RNA 和未纯化的样本

  • 快速: 50 分钟 [样品制备 5 分钟 + qRT-PCR 45 分钟/40 个循环]

  • 可靠:针对 SARS-CoV-2(S、ORF8、N)和人类(RNase P)的 4 种目标检测

  • UDG 系统:防止残留污染

产品

货号 产品 尺寸
DFSCV100 DirectFast™ SARS-CoV-2 多重检测 [仅供研究使用] 100 次
  • 描述

  •  

  •  

DirectFast ™ SARS-CoV-2 多重检测是一种基于探针的实时 RT-PCR 试剂盒,专为 SARS-CoV-2 RNA 的“直接”和“快速”检测而设计。通过裂解缓冲液 (NAExDB) 或加热制备的粗 RNA 样品以及纯化的 RNA 可用作该检测试剂盒的模板,而不会影响灵敏度和准确性。使用此快速试剂盒,反应可在一小时内快速完成实时 RT-PCR 循环(40 个循环需要 45-50 分钟)。多靶点检测( SARS-CoV-2 的ORF8、N、S基因)降低了由病毒 RNA 突变引起的假阴性结果的风险。此外,该检测还安装了不耐热的 UNG(尿嘧啶-N-糖基化酶)和 dUTP 系统,以防止残留污染。


  

图:使用 DirectFast™ SARS-CoV-2 多重检测法灵敏检测 SARS-CoV-2。将 SARS-CoV-2 病毒 RNA 以 10 6 ~ 10 1拷贝/μL的浓度加标到鼻咽拭子集合(在 UTM 中) 。根据本产品的 IFU 从每个加标样品中制备 RNA。每3μL纯化的病毒RNA作为模板用于SARS-CoV-2检测。反应在实时 PCR 仪器 Bio-Rad CFX96 上进行。

 

 

 

 

 

 

 

 

 

 

 

 

 


应用 

  • 直接实时检测 SARS-CoV-2 

 

 

质量控制

功能分析

DirectFast™ SARS-CoV-2 多重检测通过实时 RT-PCR 进行评估,使用 10 倍连续稀释纯化的 SARS-CoV-2 RNA 和 PC(SCV2),并根据协议使用目标特异性引物和水解探针提供。

Abbexa SARS-CoV-2抗原快速检测试剂盒简介

Abbexa SARS-CoV-2抗原快速检测试剂盒简介
我们还提供专业使用的cov-19抗原检测试剂盒。这是一种用于实验室和医院检测的一次性体外诊断设备。这款包罗万象的套件仅需10分钟即可产生快速、直观的效果。
这是一种定性的横向流动免疫层析法,用于检测人口咽、鼻和鼻咽拭子中的SARSCoV-2抗原。
该盒含有与金纳米颗粒结合的抗SARS-CoV-2/COVID19单克隆抗体,金纳米颗粒与样本中存在的任何SARS-CoV-2抗原结合。抗SARS-CoV-2的单克隆抗体被包裹在硝化纤维素膜上的测试区域,该膜与抗原抗体复合物结合,并由于金纳米颗粒而形成彩色线。盒式磁带上端的控制区域确认测试是否成功。
读数应在C(控制)区域显示1行。根据接触冠状病毒的情况,G(IgG)和M(IgM)区域旁边可能出现紫色线。微弱的线条被视为阳性结果

SARS-CoV-2逆转录定量PCR试剂盒
Abbexa也很高兴向客户提供我们的qPCR套件。
严重急性呼吸综合征冠状病毒2(SARS-CoV-2/COVID19)RT-qPCR试剂盒,用于在单管中高效合成cDNA和实时PCR。
该试剂盒包含一组荧光探针引物,用于区分2019 nCoV/COVID19/SARS-CoV-2和SARS-CoV(bat SARS相关CoV)。SARS-CoV-2 RNA可在FAM通道中检测到,SARS-CoV RNA可在HEX、VIC或JOE通道中检测到(取决于所用设备)。

COVID19 Kits
Catalogue Number Product Name Description
abx365044 Human SARS-CoV-2 Neutralizing Antibody ELISA Kit For the qualitative detection of
SARS-CoV-2/COVID19 Neutralizing Antibodies in
Human serum and plasma.
abx365086 Human SARS-CoV-2 Neutralizing Antibody ELISA Kit For the semi-quantitative detection of
SARS-CoV-2/COVID19 Neutralizing Antibodies in
Human serum and plasma.
abx392294 Human SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit For the qualitative detection of
SARS-CoV-2/COVID19 Nucleocapsid Protein IgG
antibodies in Human serum and plasma.
abx392295 Human SARS-CoV-2 Nucleocapsid Protein IgM ELISA Kit For the qualitative detection of
SARS-CoV-2/COVID19 Nucleocapsid Protein IgM
antibodies in Human serum and plasma.
abx365028 Human SARS-CoV-2 Spike Protein IgG ELISA Kit For the qualitative detection of
SARS-CoV-2/COVID19 Spike Protein IgG antibodies in Human serum and plasma.
abx365029 Human SARS-CoV-2 Spike Protein IgM ELISA Kit For the qualitative detection of
SARS-CoV-2/COVID19 Spike Protein IgM antibodies in Human serum and plasma.
abx365085 Human SARS-CoV-2
Spike Protein Total Antibody
ELISA Kit
For the qualitative detection of
SARS-CoV-2/COVID19 Spike Protein total antibodies in Human serum and plasma.
abx365030 SARS-CoV-2 Nucleocapsid Protein ELISA Kit For the quantitative detection of
SARS-CoV-2/COVID19 Nucleocapsid Protein in Hu- man serum, plasma and other biological fluids.
abx365031 SARS-CoV-2 Spike Protein S1 RBD ELISA Kit For the quantitative detection of
SARS-CoV-2/COVID19 Spike Protein S1 RBD in Human tissue homogenates, cell lysates, cell culture supernatants, saliva, and other biological fluids.

 

Mutant SARS-CoV-2 Recombinant Proteins
Beta (South Africa) B.1.351 Variant – K417N, E484K and N501Y Mutations
The Beta (B.1.351) variant was first identified in South Africa. It contains the K417N, E484K and N501Y mutations in the spike protein’s receptor-binding domain.
Catalogue Number Product Name Description
abx160085 SARS-CoV-2 S1
Protein RBD (Beta B.1.351 Variant)
Recombinant protein expressed in Insect cells.
Tag: C-terminal His-tag.
abx620004 SARS-CoV-2 Spike Protein RBD
(Beta B.1.351 Variant)
Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
Gamma (Brazil) P.1 Variant – K417T, E484K and N501Y Mutations
The Gamma (P.1) variant was first identified in Brazil. It contains the K417T, E484K and N501Y mutations in the spike protein’s receptor-binding domain.
Catalogue Number Product Name Description
abx160086 SARS-CoV-2 S1
Protein RBD (Gamma P.1 Variant)
Recombinant protein expressed in Insect cells.
Tag: C-terminal His-tag.
abx620006 SARS-CoV-2 Spike Protein RBD (Gamma P.1 Variant) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
Epsilon (California) B.1.429/B.1.427 (CAL.20C) Variant – L452R Mutation
The L452R mutation is present in the B.1.429/B.1.427 (CAL.20C/Epsilon) variants first identified in California, USA.
Catalogue Number Product Name Description
abx160087 SARS-CoV-2 S1
Protein RBD (L452R Mutation)
Recombinant protein expressed in Insect cells.
Tag: C-terminal His-tag.
abx620007 SARS-CoV-2 Spike Protein RBD (L452R Mutation) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.

 

Mutant SARS-CoV-2 Recombinant Proteins
India B.1.36 (AP) Variant — N450K Mutation
The N450K mutation is present in the B.1.36 variant first identified in Andhra Pradesh, India.
Catalogue Number Product Name Description
abx620011 SARS-CoV-2 Spike Protein RBD (N450K Mutation) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
Kappa (India) B.1.617.1 Variant — E484Q and L452R Double-Mutation
The B.1.617 variant was first identified in India. It contains the E484Q and L452R mutations and is therefore widely known as a “double mutation” variant. These mutations have been reported to increase binding to human ACE2 and reduce antibody neutralization of the virus, in comparison with other variants.
Catalogue Number Product Name Description
abx160088 SARS-CoV-2 S1
Protein RBD (B.1.617 Variant)
Recombinant protein expressed in Insect cells.
Tag: His-tag.
abx620009 SARS-CoV-2 Spike Protein RBD (B.1.617 Variant) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
Delta (India) B.1.617.2 Variant — L452R and T478K Double-Mutation
The B.1.617.2 (Delta) variant was first identified in India. It contains the L452R and T478K mutations, which appear to increase viral infectivity compared with other variants.
Catalogue Number Product Name Description
abx620012 SARS-CoV-2 Spike Protein RBD
(Delta B.1.617.2 Variant)
Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.

 

Mutant SARS-CoV-2 Recombinant Proteins
Delta Plus B.1.617.2 (AY.1) Variant — K417N, L452R and T478K Mutations
The B.1.617.2.1 (Delta Plus) variant, also known as AY.1, contains the K417N mutation as well as the L452R and T478K mutations in the original B.1.617.2 (Delta) variant. These mutations appear to increase viral infectivity compared with other variants.
Catalogue Number Product Name Description
abx620018 SARS-CoV-2 Spike Protein RBD
(Delta Plus B.1.617.2.1 Variant)
Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
Other Mutations
The E484K mutation is present in several variants, including those first identified in South Africa and Brazil. This mutation has been reported to reduce antibody neutralization of the virus.
The S477N mutation has been reported to increase binding to human ACE2.
Catalogue Number Product Name Description
abx620005 SARS-CoV-2 Spike Protein RBD (E484K Mutation) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
abx620008 SARS-CoV-2 Spike Protein RBD (S477N Mutation) Recombinant protein expressed in Mammalian cells.
Tag: C-terminal His-tag.
SARS-CoV-2 Antibody Pairs
Catalogue Number Product Name Description
abx024239 SARS-CoV-2/COVID19
Nucleocapsid Protein
Antibody
Mouse Monoclonal against SARS-CoV-2/
COVID19 NP (Capture Antibody)
abx024238 SARS-CoV-2/COVID19
Nucleocapsid Protein
Antibody
Mouse Monoclonal against SARS-CoV-2/
COVID19 NP (Detection Antibody)
abx024240 SARS-CoV-2/COVID19 Trimer-
ic Spike 1 Protein Antibody
Mouse Monoclonal against SARS-CoV-2/ COVID19 Trimeric S1 Protein (Capture Antibody)
abx024241 SARS-CoV-2/COVID19 Trimer-
ic Spike 1 Protein Antibody
Mouse Monoclonal against SARS-CoV-2/ COVID-9 Trimeric S1 Protein (Detection Antibody)
abx243136 SARS-CoV-2/COVID19
Spike Glycoprotein RBD Antibody Pair
Contains a recombinant Llama with Human IgG1 Fc capture antibody, and recombinant Mouse with Human IgG1 Fc detection antibody.